ATE142883T1 - Zusammensetzungen von phytosterolen mit phytosterolinen als immunmodulatoren - Google Patents

Zusammensetzungen von phytosterolen mit phytosterolinen als immunmodulatoren

Info

Publication number
ATE142883T1
ATE142883T1 AT92302556T AT92302556T ATE142883T1 AT E142883 T1 ATE142883 T1 AT E142883T1 AT 92302556 T AT92302556 T AT 92302556T AT 92302556 T AT92302556 T AT 92302556T AT E142883 T1 ATE142883 T1 AT E142883T1
Authority
AT
Austria
Prior art keywords
phytosterolins
phytosterols
compositions
immune modulators
sitosterol
Prior art date
Application number
AT92302556T
Other languages
English (en)
Inventor
Patrick Jacques Desire Bouic
Carl Franz De Vos Albrecht
Original Assignee
Rooperol Na Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rooperol Na Nv filed Critical Rooperol Na Nv
Application granted granted Critical
Publication of ATE142883T1 publication Critical patent/ATE142883T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
AT92302556T 1991-03-28 1992-03-25 Zusammensetzungen von phytosterolen mit phytosterolinen als immunmodulatoren ATE142883T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ZA912349 1991-03-28

Publications (1)

Publication Number Publication Date
ATE142883T1 true ATE142883T1 (de) 1996-10-15

Family

ID=25580597

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92302556T ATE142883T1 (de) 1991-03-28 1992-03-25 Zusammensetzungen von phytosterolen mit phytosterolinen als immunmodulatoren

Country Status (5)

Country Link
US (1) US5486510A (de)
EP (1) EP0509656B1 (de)
JP (1) JPH06172183A (de)
AT (1) ATE142883T1 (de)
DE (1) DE69213804T2 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19701264A1 (de) 1997-01-16 1998-07-23 Kief Lizenz Verwertungsgesells Heilmittel, enthaltend Betasitosterin und/oder Phytosterol/Betasitosteringemische
ATE222107T1 (de) * 1997-02-18 2002-08-15 Rooperol Na Nv Verwendung einer kombination von beta-sitosterol und beta-sitosterol-glukosid zur herstellung eines medikamentes zur behandlung von hiv- infektion
FR2798591B1 (fr) 1999-09-22 2001-10-26 Pharmascience Lab Utilisation d'un produit d'huile vegetale pour augmenter la synthese des lipides cutanes en cosmetique, pharmacie ou dermatologie et en tant qu'additif alimentaire
AU2002223317A1 (en) 2000-11-03 2002-05-15 The University Of British Columbia Sterol glucoside toxins
CN1827766B (zh) * 2001-06-28 2010-08-25 徐荣祥 体外细胞的培养方法
US6685971B2 (en) * 2001-06-28 2004-02-03 Rongxiang Xu Method and composition for repairing and promoting regeneration of mucosal tissue in the gastrointestinal tract
US6972195B2 (en) * 2002-09-27 2005-12-06 Rongxiang Xu Composition and method for culturing potentially regenerative cells and functional tissue-organs in vitro
US6979470B2 (en) * 2001-07-17 2005-12-27 Metaproteomics, Llc Curcuminoid compositions exhibiting synergistic inhibition of the expression and/or activity of cyclooxygenase-2
GB0329667D0 (en) * 2003-12-22 2004-01-28 King S College London Core 2 GlcNAc-T inhibitor
GB0513881D0 (en) * 2005-07-06 2005-08-10 Btg Int Ltd Core 2 GLCNAC-T Inhibitors III
US20080182801A1 (en) * 2003-12-22 2008-07-31 Btg International Limited Core 2 glcnac-t inhibitors
JP2005255568A (ja) * 2004-03-10 2005-09-22 Picaso Cosmetic Laboratory Ltd α−グルコシダーゼ阻害剤
GB0512726D0 (en) * 2005-06-22 2005-07-27 Btg Int Ltd Multiple sclerosis therapy and diagnosis
GB0513888D0 (en) * 2005-07-06 2005-08-10 Btg Int Ltd Core 2 GLCNAC-T Inhibitors II
GB0513883D0 (en) * 2005-07-06 2005-08-10 Btg Int Ltd Diagnosis of Atherosclerosis
EP1792619A1 (de) 2005-11-28 2007-06-06 Laboratorios Maymo, S.A. Beta-sitosterol zur Behandlung von Erkrankungen der Atemwege bei Schweinen
CA2632903C (en) 2005-12-02 2015-11-24 Vianova Labs, Inc. Treatment of cancer and other diseases
CA2615372A1 (en) 2007-07-13 2009-01-13 Marc-Andre D'aoust Influenza virus-like particles (vlps) comprising hemagglutinin
PT2610345E (pt) 2007-11-27 2016-01-11 Medicago Inc Partículas semelhantes ao vírus (vlps) da gripe recombinantes produzidas em plantas transgénicas que expressam hemaglutinina
EP2294202B1 (de) * 2008-07-08 2015-05-20 Medicago Inc. Lösliche rekombinante influenza-antigene
WO2010048710A1 (en) 2008-10-31 2010-05-06 Neurodyn, Inc. Neurotoxic sterol glycosides
JP5871796B2 (ja) 2009-06-24 2016-03-01 メディカゴ インコーポレイテッド ヘマグルチニンを含むキメラインフルエンザウイルス様粒子
ES2662778T3 (es) 2009-09-22 2018-04-09 Medicago Inc. Método de preparación de proteínas derivadas de plantas
US8039025B1 (en) 2010-10-15 2011-10-18 Life Plus, LLC Methods and dosage forms for the treatment of human cancers
TWI620816B (zh) 2011-03-23 2018-04-11 苜蓿股份有限公司 植物衍生蛋白回收方法
KR20130011111A (ko) * 2011-07-20 2013-01-30 신일제약주식회사 피토스테롤계 화합물을 포함하는 염증성 질환의 예방 또는 치료용 약학적 조성물
CN103518752B (zh) * 2013-10-08 2014-12-10 陕西上格之路生物科学有限公司 一种胡萝卜苷类化合物作为抗病毒剂的应用
CN112618665B (zh) * 2020-12-19 2022-06-14 杭州益品新五丰药业有限公司 一种提高免疫反应的糠甾醇-谷维素联合用药制剂

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE35018B1 (en) * 1970-03-18 1975-10-15 Liebenberg R W Therapeutic agent
ZA72698B (en) * 1972-02-03 1973-09-26 Liebenberg R W Method of preparing medicinal compositions
DE2659466A1 (de) * 1976-12-30 1979-02-15 Roecar Holdings Nv Steroline und deren verwendung
US4254111A (en) * 1978-07-05 1981-03-03 Roecar Holdings (Netherlands Antilles) Nv Sterolin products
US4260603A (en) * 1979-01-02 1981-04-07 Pegel Karl H Sterol glycoside with activity as prostaglandin synthetase inhibitor
DE3416112A1 (de) * 1984-04-30 1985-10-31 Roecar Holdings (Netherlands Antilles) N.V., Willemstad, Curacao, Niederländische Antillen Verwendung von sterolinen und spiroketalinen als lipoxygenaseregulatoren
IT1203515B (it) * 1987-02-26 1989-02-15 Indena Spa Complessi di saponine con fosfolipidi e composizioni farmaceutiche e cosmetiche che li contengono
DE3829641A1 (de) * 1988-09-01 1990-03-15 Roecar Holdings Nv Transdermal anwendbare pharmazeutische zubereitungen mit sterolinen und/oder spiroketalinen

Also Published As

Publication number Publication date
US5486510A (en) 1996-01-23
EP0509656B1 (de) 1996-09-18
DE69213804T2 (de) 1997-03-27
JPH06172183A (ja) 1994-06-21
DE69213804D1 (de) 1996-10-24
EP0509656A1 (de) 1992-10-21

Similar Documents

Publication Publication Date Title
ATE142883T1 (de) Zusammensetzungen von phytosterolen mit phytosterolinen als immunmodulatoren
DK0668769T3 (da) Egebarkekstrakt-relaterede syntetiske sammensætninger og fremgangsmåde til deres anvendelse
DE3880766D1 (de) Konjugate von interferon alpha mit immunglobulinen.
DE69132048D1 (de) Verwendung von Steroiden zur Inhibierung von Angiogenesis
FI943805A0 (fi) Substituoituja adeniinijohdannaisten käyttö multippeliskleroosin hoitoon
ATE281840T1 (de) Behandlung von diarrhoe
AU6760987A (en) Method of treating alzheimer's disease
AU7679787A (en) Expression of a tumor-specific antigen by a recombinant vector virus and use thereof in preventive or curative treatment of the corresponding tumor
AU7751987A (en) Treatment of bacterial diseases with granulocyte-macrophage colony stimulating factor
GB8805792D0 (en) Medicaments
DE68924319D1 (de) Als therapeutische mittel verwendbare substituierte adeninderivate.
ATE162200T1 (de) Bisaminierte zyklohexapeptide
ATE88343T1 (de) Anxiolytisches praeparat.
AU7426487A (en) Method of treating depression using d-fenfluramine
ATE86492T1 (de) Anwendung von sterolinen und spiroketalinen zur herstellung von medikamenten zur behandlung von psoriasis.
ATE45675T1 (de) Verwendung von interferon gamma (ifn-gamma) zur herstellung von praeparationen zur behandlung rheumatischer erkrankungen.
NZ216519A (en) Polycyclic compounds and pharmaceutical compositions
ATE164882T1 (de) Verfahren zur herstellung von aktivierten killer- monozyten und verfahren zur überprüfung ihrer tumoriziden aktivität
DE69227897D1 (de) Darstellung und verwendung von butyrylcholinesterase
AU2525488A (en) Use of metalloporphyrins to reverse the toxic effect of tumor therapy
DE69017825D1 (de) Heilverfahren von Lebererkrankungen mit Verwendung von Pyrrol-Chinolin-Chinone-Triester und neue Pyrrol-Chinolin-Chinone-Triester.
ATE130194T1 (de) Subkutane verabreichung des humanen choriongonadotropins.
FI871568A0 (fi) Arylsubstituerade naftyridin- och pyridopyrazinderivat.
DE3485282D1 (de) Zusammensetzung zur behandlung von boesartigen tumoren insbesondere bei tieren.
GB2233559A (en) Antibodies for use in antilymphocyte antibody therapy

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee